HomeCompareHKMPF vs PLD

HKMPF vs PLD: Dividend Comparison 2026

HKMPF yields 4.85% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HKMPF wins by $296.65M in total portfolio value
10 years
HKMPF
HKMPF
● Live price
4.85%
Share price
$17.30
Annual div
$0.84
5Y div CAGR
85.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$302.56M
Annual income
$279,218,818.50
Full HKMPF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — HKMPF vs PLD

📍 HKMPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHKMPFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HKMPF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HKMPF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HKMPF
Annual income on $10K today (after 15% tax)
$412.45/yr
After 10yr DRIP, annual income (after tax)
$237,335,995.73/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, HKMPF beats the other by $233,297,879.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HKMPF + PLD for your $10,000?

HKMPF: 50%PLD: 50%
100% PLD50/50100% HKMPF
Portfolio after 10yr
$154.23M
Annual income
$141,984,771.84/yr
Blended yield
92.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

HKMPF
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
3.5
Piotroski
7/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HKMPF buys
0
PLD buys
0
No recent congressional trades found for HKMPF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHKMPFPLD
Forward yield4.85%3.10%
Annual dividend / share$0.84$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR85.6%74.4%
Portfolio after 10y$302.56M$5.91M
Annual income after 10y$279,218,818.50$4,750,725.19
Total dividends collected$300.79M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: HKMPF vs PLD ($10,000, DRIP)

YearHKMPF PortfolioHKMPF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$11,601$900.60$11,241$540.96+$360.00HKMPF
2$14,225$1,812.21$13,019$991.13+$1.2KHKMPF
3$19,075$3,854.51$15,801$1,870.97+$3.3KHKMPF
4$29,376$8,965.67$20,609$3,701.21+$8.8KHKMPF
5$55,382$23,949.87$29,919$7,867.97+$25.5KHKMPF
6$137,579$78,320.34$50,631$18,617.74+$86.9KHKMPF
7$484,693$337,482.73$105,528$51,352.20+$379.2KHKMPF
8$2,580,955$2,062,333.89$287,364$174,449.42+$2.29MHKMPF
9$21,810,404$19,048,782.00$1,081,760$774,280.77+$20.73MHKMPF
10$302,555,951$279,218,818.50$5,908,209$4,750,725.19+$296.65MHKMPF

HKMPF vs PLD: Complete Analysis 2026

HKMPFStock

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

Full HKMPF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this HKMPF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HKMPF vs SCHDHKMPF vs JEPIHKMPF vs OHKMPF vs KOHKMPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.